Shoko Inatani
4PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 04, 2023
Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis.Takashi Hirata, Hiroki Ohara, Naoki Kojima
|Feb 08, 2023
Preclinical Metabolism and Disposition of TP0473292, a Novel Oral Prodrug of the Potent Metabotropic Glutamate 2/3 Receptor Antagonist TP0178894 for the Treatment of Depression.Shoko Inatani, Motoki Ochi, Kohnosuke Kinoshita
|Nov 01, 2022
Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.Madoka Kawamura, Yohei Kobashi, Hiroaki Tanaka
|Mar 18, 2021
Prediction of a clinically effective dose of THY1773, a novel V1B receptor antagonist, based on preclinical data.Shoko Inatani, Akiko Mizuno-Yasuhira, Makoto Kamiya
Pageof 1
![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [<sup>11</sup>C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=75)
